VesselSens: First Research Group at Life Science Inkubator Bonn to Receive Funding from EXIST Program
VesselSens is the first research group based at Life Science Inkubator (LSI) Bonn, Germany, to receive funding from the…
VesselSens is the first research group based at Life Science Inkubator (LSI) Bonn, Germany, to receive funding from the…
Physicians demonstrated that reducing metal burden in superficial femoral artery (SFA) therapy could effectively reduce…
BIOTRONIK announced the presentation of data confirming the efficacy of the Pulsar-18* bare metal self-expanding stent (…
BIOTRONIK announced results establishing the Orsiro* hybrid drug-eluting stent (DES) as non-inferior to competing Resolu…
Randomized Controlled Trial Establishes Pantera Lux as a Viable Alternative to a Latest Generation Limus Eluting Stent i…
BIOTRONIK, a leader in cardio- and endovascular medical technology, announced today that it has received CE mark approva…
BIOTRONIK, a leading manufacturer of cardio- and endovascular medical devices, announced today that the results from the…
BIOTRONIK, a leading manufacturer of cardio- and endovascular medical technology, announced today that the first patient…
BIOTRONIK, a leading manufacturer of cardio- and endovascular medical technology, announced today that the first US pati…
BIOTRONIK, a leading manufacturer of cardio- and endovascular medical devices, announced the publication of promising cl…